Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model (Q44184297)

30 November 2017

title

Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model (English)

1 reference

30 November 2017

0 references

1 reference

9

1 reference

30 November 2017

1

Kristiina Tyynelä

1 reference

30 November 2017

Anu-Maaria Sandmair

2

1 reference

30 November 2017

Marita Turunen

3

1 reference

30 November 2017

Ritva Vanninen

4

1 reference

30 November 2017

Pauli Vainio

5

1 reference

30 November 2017

Risto Kauppinen

6

1 reference

30 November 2017

Risto Johansson

7

1 reference

30 November 2017

Matti Vapalahti

8

1 reference

30 November 2017

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

9

1 reference

30 November 2017

issue

11

1 reference

30 November 2017

page(s)

917-924

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700515

30 November 2017

exact match

0 references

cites work

Reoperation in the treatment of recurrent intracranial malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

Adenovirus-mediated gene therapy of experimental gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700515

21 January 2018

Identifiers

DOI

10.1038/SJ.CGT.7700515

1 reference

30 November 2017

1 reference